Hexaell Biotech

Hexaell Biotech Co., Ltd. was founded in 2015 and is located in the core area of Shanghai Jiading Industrial Park. The company possesses internationally leading cell differentiation and production technology and is a new biopharmaceutical technology company focusing on severe liver diseases and cell therapy.The company's founders come from top international academic research institutes and leading pharmaceutical companies, committed to developing the world's most advanced innovative biomedicine technologies and products to provide better clinical solutions for patients.In July 2017, HEXAELL biotech built the first domestic human-derived bioartificial liver clinical research and development production line in Shanghai Jiading. Leaders from the Shanghai municipal government and Jiading district attended the company’s inauguration ceremony. Currently, the company is actively conducting clinical research and registration-related work, with the product expected to enter the market within 3-5 years, benefiting more patients.